Drug Shortage Report for GENOTROPIN
| Report ID | 191669 |
| Drug Identification Number | 02401819 |
| Brand name | GENOTROPIN |
| Common or Proper name | GENOTROPIN |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | SOMATROPIN |
| Strength(s) | 1.6MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 7 PACK |
| ATC code | H01AC |
| ATC description | ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-05-10 |
| Actual start date | 2023-05-10 |
| Estimated end date | 2023-06-21 |
| Actual end date | 2023-06-14 |
| Shortage status | Resolved |
| Updated date | 2023-06-15 |
| Company comments | All other Genotropin presentations remain available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-06-15 | French | Compare |
| v4 | 2023-06-15 | English | Compare |
| v3 | 2023-05-11 | English | Compare |
| v2 | 2023-05-04 | French | Compare |
| v1 | 2023-05-04 | English | Compare |
Showing 1 to 5 of 5